These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22715214)

  • 21. How the response to the epidemic of HIV infection has strengthened the public health system.
    Noble GR
    Public Health Rep; 1991; 106(6):608-15. PubMed ID: 1659706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France.
    Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M
    Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global epidemiology of hepatitis C virus infection.
    Shepard CW; Finelli L; Alter MJ
    Lancet Infect Dis; 2005 Sep; 5(9):558-67. PubMed ID: 16122679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social inclusion and hepatitis C: exploring new possibilities for prevention.
    Treloar C; Valentine K; Fraser S
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):397-404. PubMed ID: 21504397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Backmund M; Reimer J; Meyer K; Gerlach JT; Zachoval R
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S330-5. PubMed ID: 15768343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.
    Suryaprasad AG; White JZ; Xu F; Eichler BA; Hamilton J; Patel A; Hamdounia SB; Church DR; Barton K; Fisher C; Macomber K; Stanley M; Guilfoyle SM; Sweet K; Liu S; Iqbal K; Tohme R; Sharapov U; Kupronis BA; Ward JW; Holmberg SD
    Clin Infect Dis; 2014 Nov; 59(10):1411-9. PubMed ID: 25114031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.
    Pereira GA; Stefani MM; Martelli CM; Turchi MD; Siqueira EM; Carneiro MA; Martins RM
    J Med Virol; 2006 Jun; 78(6):719-23. PubMed ID: 16628586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.
    Alter MJ; Kruszon-Moran D; Nainan OV; McQuillan GM; Gao F; Moyer LA; Kaslow RA; Margolis HS
    N Engl J Med; 1999 Aug; 341(8):556-62. PubMed ID: 10451460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
    Winslow M; Subramaniam M; Ng WL; Lee A; Song G; Chan YH
    Singapore Med J; 2007 Jun; 48(6):504-8. PubMed ID: 17538746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.
    Curcio F; Villano G; Masucci S; Plenzik M; Veneruso C; De Rosa G
    J Addict Med; 2011 Mar; 5(1):43-9. PubMed ID: 21769046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV and hepatitis C virus infection in the United States: whom and how to test.
    Panneer N; Lontok E; Branson BM; Teo CG; Dan C; Parker M; Stekler JD; DeMaria A; Miller V
    Clin Infect Dis; 2014 Sep; 59(6):875-82. PubMed ID: 24867787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
    Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
    Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.
    Wand H; Spiegelman D; Law M; Jalaludin B; Kaldor J; Maher L
    Addiction; 2009 Dec; 104(12):2049-56. PubMed ID: 19804463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000.
    Hammer GP; Kellogg TA; McFarland WC; Wong E; Louie B; Williams I; Dilley J; Page-Shafer K; Klausner JD
    Sex Transm Dis; 2003 Dec; 30(12):919-24. PubMed ID: 14646642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C: Part I. Routine serologic testing and diagnosis.
    Moyer LA; Mast EE; Alter MJ
    Am Fam Physician; 1999 Jan; 59(1):79-88, 91-2. PubMed ID: 9917576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.